Metraipolis › archive › dc_0e12d42e4c03

Machine learning-derived genetic risk scores identify IL21 as a predictor of response to omalizumab and dupilumab in asthma — Europe PMC PMID:41104387

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41104387
DOI
10.3389/falgy.2025.1670783
License (as archived)
solo-consultazione
Archived
2026-11-09T15:52:37.736Z
SHA-256 of the archived text
a286ee10b34586194419fbe27153075b28c4ad515be3aa02b86ca4c2e161ab6f
Stable URL of this page
https://metraipolis.com/documento/dc_0e12d42e4c03

How to cite

Machine learning-derived genetic risk scores identify IL21 as a predictor of response to omalizumab and dupilumab in asthma — Europe PMC PMID:41104387 — Europe PMC (en), https://europepmc.org/article/MED/41104387 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0e12d42e4c03 (Metraipolis archive dc_0e12d42e4c03, sha256 a286ee10b34586194419fbe27153075b28c4ad515be3aa02b86ca4c2e161ab6f)
BibTeX
@misc{dc0e12d42e4c03,
  title = {Machine learning-derived genetic risk scores identify IL21 as a predictor of response to omalizumab and dupilumab in asthma — Europe PMC PMID:41104387},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41104387},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0e12d42e4c03; sha256 a286ee10b34586194419fbe27153075b28c4ad515be3aa02b86ca4c2e161ab6f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41104387. Agents can read the archived copy with the MCP tool read_document.